The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
JBG SMITH COM | COM | 46590V100 | 64,814 | 1,759,817 | SH | SOLE | 0 | 0 | 1,759,817 | ||
PPDAI GROUP INC | SPONSORED ADR | 69354V108 | 900 | 167,223 | SH | SOLE | 0 | 0 | 167,223 | ||
RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | 1,390 | 47,643 | SH | SOLE | 0 | 0 | 47,643 | ||
VOYAGER THERAPEUTICS | COM | 92915B106 | 3,853 | 203,632 | SH | SOLE | 0 | 0 | 203,632 |